Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2024-02-22
Original market date: See footnote 1
1994-12-31
Product name:
SANTYL
DIN:
02063670
Product Monograph/Veterinary Labelling:
Date:
2023-12-07
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SMITH & NEPHEW INC
2280 Argentia Rd
Mississauga
Ontario
Canada
L5N 6H8
Class:
Human
Dosage form(s):
Ointment
Route(s) of administration:
Topical
Number of active ingredient(s):
1
Schedule(s):
Prescription , Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
84:92.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
D03BA02 COLLAGENASE
Active ingredient group (AIG) number:See footnote5
0112254001
| Active ingredient(s) | Strength |
|---|---|
| COLLAGENASE | 250 UNIT / G |